Groups | Dose (mg/kg) | Serum lipid levels (mg/dL) | ||
TC | TG | HDL | ||
Control | Vehicle | 75.32 ± 2.51 | 88.36 ± 2.34 | 63.71 ± 1.34 |
Diabetic control | Vehicle | 129.31 ± 3.21a | 147.27 ± 3.39a | 41.50 ± 1.67a |
HAFE | 100 | 80.36 ± 0.77b | 94.88 ± 3.84b | 60.71 ± 2.69b |
HAFE | 200 | 74.37 ± 2.84b | 82.74 ± 0.34b | 52.18 ± 1.64c |
HALE | 100 | 75.37 ± 2.11b | 87.63 ± 1.81b | 56.76 ± 1.56b |
HALE | 200 | 73.75 ± 0.14b | 81.28 ± 1.84b | 51.33 ± 3.33c |
Glibenclamide (Standard) | 5 | 72.46 ± 1.26b | 74.54 ± 3.17b | 60.81 ± 2.19b |